What is the best country for stem cell therapy for Multiple Sclerosis?
There is no evidence-based country ranking. Compare specialist selection criteria, transplant accreditation where relevant, protocol authorisation, product identity, infection and intensive-care capability, long-term follow-up and transparent outcomes.
The cost picture for Multiple Sclerosis
Do not compare a commercial infusion quote with AHSCT or disease-modifying therapy as if they were the same intervention. Itemise conditioning, hospital care, product, monitoring, infection prevention, travel, follow-up and complication responsibility, and obtain an independent MS specialist's review.
Am I a candidate? → · Multiple Sclerosis: full overview → · Multiple Sclerosis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Multiple Sclerosis: cell-therapy evidence and registered trials
- How much does stem cell therapy for Multiple Sclerosis cost? (2026)
- Multiple Sclerosis stem cell therapy — your questions answered (2026)
- Multiple Sclerosis: cell-therapy evidence by therapy class
- MSC vs HSCT for Multiple Sclerosis: what the registries show